أستونيا - الإستونية - Ravimiamet

organon n.v. - desogestreel+etünüülöstradiool - tablett - 0,15mg+0,03mg 63tk

أستونيا - الإستونية - Ravimiamet

aspen pharma trading limited - desogestreel+etünüülöstradiool - tablett - 25mcg+40mcg/125mcg+30mcg 21tk / 45tk; 25mcg+40mcg/125mcg+30mcg 7tk / 15tk

أستونيا - الإستونية - Ravimiamet

organon n.v. - desogestreel+etünüülöstradiool - tablett - 0,15mg+0,02mg 63tk

أستونيا - الإستونية - Ravimiamet

aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a. - fentanüül - keelealune tablett - 533mcg 3tk; 533mcg 4tk; 533mcg 30tk; 533mcg 15tk

أستونيا - الإستونية - Ravimiamet

aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a. - fentanüül - keelealune tablett - 267mcg 15tk; 267mcg 30tk

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

pfizer europe ma eeig - glasdegib maleate - leukeemia, müeloidne, äge - antineoplastilised ained - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - seedetraktist esinevad stromaal-kasvajad - muud antineoplastilised ained, protein kinase inhibiitorid - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosupressandid - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

pfizer europe ma eeig  - rimegepant - migreenihäired - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

أستونيا - الإستونية - Ravimiamet

alfasan nederland b.v. - levometadoon+fenpipramiid - süstelahus - 2,5mg+0,125mg 1ml 5ml 1tk; 2,5mg+0,125mg 1ml 10ml 1tk